232 related articles for article (PubMed ID: 36105062)
1. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
Hao X; Li Y; Huang G; Zeng Y
Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
Liang C; Wang S; Zhang M; Li T
J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
[TBL] [Abstract][Full Text] [Related]
3. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database.
Dai B; Sun F; Cai X; Li C; Liu H; Shang Y
Front Genet; 2021; 12():634162. PubMed ID: 33763115
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
Front Genet; 2022; 13():1044264. PubMed ID: 36544487
[No Abstract] [Full Text] [Related]
5. Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
Zhou Y; Fang C; Sun Q; Dong Y
Front Genet; 2022; 13():939175. PubMed ID: 35910226
[TBL] [Abstract][Full Text] [Related]
6. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
[TBL] [Abstract][Full Text] [Related]
8. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
[TBL] [Abstract][Full Text] [Related]
9. Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis.
Huang G; Huang S; Cui H
Front Pharmacol; 2022; 13():993567. PubMed ID: 36518679
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
12. Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease.
Hui Y; Ma Q; Zhou XR; Wang H; Dong JH; Gao LN; Zhang T; Li YY; Gong T
Sci Rep; 2023 Sep; 13(1):14588. PubMed ID: 37666846
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
Zhou S; Hua R; Quan S
J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
[TBL] [Abstract][Full Text] [Related]
14. Expression of m6A Regulator Genes can Facilitate the Diagnosis of Chronic Heart Failure.
Zhou F; Yu Y; Li Y; Chen J; Wen S; Liu N; Li X; Bai R; Yan W
Heart Surg Forum; 2023 Oct; 26(5):E485-E497. PubMed ID: 37920080
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
16. N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis.
Ye F; Wang T; Wu X; Liang J; Li J; Sheng W
J Transl Med; 2021 Jul; 19(1):316. PubMed ID: 34294105
[TBL] [Abstract][Full Text] [Related]
17. The risk of COVID-19 can be predicted by a nomogram based on m6A-related genes.
Lu L; Li Y; Ao X; Huang J; Liu B; Wu L; Li D
Infect Genet Evol; 2022 Dec; 106():105389. PubMed ID: 36460278
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes based on N6-methyladenosine RNA methylation demonstrate the heterogeneity of immune and biological functions in pediatric septic shock.
Wang H; Huang J; Guo C; Wu J; Zhang L; Ren X; Gan L
Heliyon; 2023 Oct; 9(10):e20714. PubMed ID: 37842565
[TBL] [Abstract][Full Text] [Related]
19. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
20. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
